Multiple Sclerosis, Chronic Progressive
19
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 19 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (19)
Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
Exercise Effects in Multiple Sclerosis
Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS
Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)
Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis
MUSCLE - Nordic Walking in MUltiple SCLErosis
Follow-up Study of the Effectiveness of Virtual Reality Therapy in MS Patients
Sensitivity of Motor Assessment in MS - a Prospective Cohort Study
Rotating Frame Relaxation Imaging in Patients With Multiple Sclerosis
The Effect of Neurorehabilitation Therapy on Postural Control, Mobility and Quality of Life in Multiple Sclerosis Patients
Intrathecal Rituximab in Progressive Multiple Sclerosis
Evidence Based Patient Information and Smartphone Accelerometry to Enhance Physical Activity in MS
Lipoic Acid for Secondary Progressive Multiple Sclerosis (MS)
China Betaferon Adherence, Coping and Nurse Support Study
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis
Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients